07 April 2020
“A single dose of antibodies drawn from the blood of Covid-19 survivors appears to have improved the symptoms of 10 patients severely ill with the disease, according to new research. As the Press Association reports, the treatment, known as convalescent plasma (CP) therapy, involves using antibody-rich blood plasma of those who have recovered from coronavirus, which can neutralise the bug to fight infection.
Scientists in China who conducted the preliminary study said no serious adverse reactions were observed after CP transfusion, PA reports. They believe the findings, published in the journal Proceedings of the National Academy of Sciences, suggest that CP therapy might be a safe and promising treatment for severe Covid-19 patients, and add further investigation is needed in controlled clinical trials.” – The Guardian